OBJECTIVE: To treat binocular @entity892 secondary to macular pathology. METHODS: Seven @entity1 underwent evaluation and treatment. All had constant @entity892 caused by various @entity1020 , including @entity2295 , epiretinal membrane, and @entity989 . Visual acuity ranged from 20/20 to 20/30 in the affected eye. All except 1 @entity1 had a small-angle, comitant hyperdeviation with no muscle paresis. Sensory evaluation demonstrated peripheral fusion and reduced stereoacuity. Neither prism correction nor manipulation of the @entity2516 corrected the @entity892 . A partially occlusive foil (Bangerter) of density ranging from 0.4 to 1.0 was placed in front of the affected eye to restore stable, single vision. RESULTS: The Bangerter foil eliminated the @entity892 in all @entity1 . Two @entity1 elected not to wear the foil; 1 @entity1 was afraid of becoming dependent, and the other was bothered by the visual blur. Visual acuity in the affected eye was reduced on average by 3 lines. All @entity1 maintained the same level of sensory fusion, with only 2 having reduced stereoacuity. Symptoms returned when the foil was removed or its density was reduced. CONCLUSION: Low-density Bangerter foils provide an effective, inexpensive, and aesthetically acceptable management for refractory binocular @entity892 induced by macular pathology, allowing peripheral fusion to be maintained.

Nonsurgical management of binocular XXXX induced by macular pathology.

@entity1 :: ('9606', 'Species') :: ['patients', 'patient'] @entity2516 :: ('MESH:D012030', 'Disease') :: ['refractive errors'] @entity2295 :: ('MESH:D015861', 'Disease') :: ['subretinal neovascularization'] @entity989 :: ('MESH:D012164', 'Disease') :: ['central serous retinopathy'] @entity892 :: ('MESH:D004172', 'Disease') :: ['vertical diplopia', 'diplopia'] @entity1020 :: ('MESH:D008268', 'Disease') :: ['maculopathies']
@entity892 :: (MESH:D004172,Disease) :: ['diplopia']
